NASDAQ:PLUR Pluri Q4 2025 Earnings Report $1.05 -0.01 (-0.94%) Closing price 04:00 PM EasternExtended Trading$1.02 -0.03 (-2.38%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Pluri EPS ResultsActual EPS-$2.62Consensus EPS -$0.73Beat/MissMissed by -$1.89One Year Ago EPSN/APluri Revenue ResultsActual Revenue$0.91 millionExpected Revenue$0.40 millionBeat/MissBeat by +$510.00 thousandYoY Revenue GrowthN/APluri Announcement DetailsQuarterQ4 2025Date9/17/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsPluri's next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Pluri Earnings HeadlinesiBio (NASDAQ:IBIO) & Pluri (NASDAQ:PLUR) Financial ContrastSeptember 21 at 4:45 AM | americanbankingnews.comPluri (PLUR) to Release Quarterly Earnings on WednesdaySeptember 16, 2026 | americanbankingnews.comThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.September 24 at 1:00 AM | Golden Portfolio (Ad)Pluri Inc. Reports Earnings Results for the Full Year Ended June 30, 2026September 10, 2026 | marketscreener.comMPluri Announces August 2026 Equity Financing TransactionAugust 28, 2026 | tipranks.comPluri prices $3.3 million offeringAugust 27, 2026 | seekingalpha.comSee More Pluri Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Pluri? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pluri and other key companies, straight to your email. Email Address About PluriPluri (NASDAQ:PLUR) Ltd. is an Israel-based biotechnology company that develops cell-based products using its proprietary three-dimensional cell expansion technology. The platform is designed to produce large quantities of potentially therapeutic and commercial cells while maintaining consistent quality and scalability. The company’s research and development activities have included placenta-derived, off-the-shelf cell therapies, historically marketed under the PLX platform. These programs have targeted areas such as regenerative medicine, inflammation, cancer, orthopedic conditions and other medical needs. Pluri has also expanded its technology applications into areas including cell-based food and other non-pharmaceutical products. Founded as Pluristem Therapeutics, the company adopted the name Pluri Ltd. in 2022. It is headquartered in Haifa, Israel, and develops its products for potential use in global healthcare and biotechnology markets through research programs and strategic collaborations. Yaky Yanay serves as the company’s chief executive officer.View Pluri ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just StrengthenedEnergy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock? Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
